Literature DB >> 23085944

Induction of M2-like macrophages in recipient NOD-scid mice by allogeneic donor CD4(+)CD25(+) regulatory T cells.

Xuelian Hu1, Guangwei Liu, Yuzhu Hou, Jianfeng Shi, Linnan Zhu, Di Jin, Jianxia Peng, Yong Zhao.   

Abstract

CD4(+)CD25(+) regulatory T cells (Tregs) play an important role in maintaining host immune tolerance via regulation of the phenotype and function of the innate and adaptive immune cells. Whether allogeneic CD4(+)CD25(+) Tregs can regulate recipient mouse macrophages is unknown. The effect of allogeneic donor CD4(+)CD25(+) Tregs on recipient mouse resident F4/80(+)macrophages was investigated using a mouse model in which allogeneic donor CD4(+)CD25(+) Tregs were adoptively transferred into the peritoneal cavity of host NOD-scid mice. The phenotype and function of the recipient macrophages were then assayed. The peritoneal F4/80(+) macrophages in the recipient mice that received the allogeneic CD4(+)CD25(+) Tregs expressed significantly higher levels of CD23 and programmed cell death-ligand 1(PD-L1) and lower levels of CD80, CD86, CD40 and MHC II molecules compared to the mice that received either allogeneic CD4(+)CD25(-) T cells (Teffs) or no cells. The resident F4/80(+) macrophages of the recipient mice injected with the allogeneic donor CD4(+)CD25(+) Tregs displayed significantly increased phagocytosis of chicken red blood cells (cRBCs) and arginase activity together with increased IL-10 production, whereas these macrophages also showed decreased immunogenicity and nitric oxide (NO) production. Blocking arginase partially but significantly reversed the effects of CD4(+)CD25(+) Tregs with regard to the induction of the M2 macrophages in vivo. Therefore, the allogeneic donor CD4(+)CD25(+) Tregs can induce the M2 macrophages in recipient mice at least in part via an arginase pathway. We have provided in vivo evidence to support the unknown pathways by which allogeneic donor CD4(+)CD25(+) Tregs regulate innate immunity in recipient mice by promoting the differentiation of M2 macrophages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23085944      PMCID: PMC4002221          DOI: 10.1038/cmi.2012.47

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  44 in total

1.  Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages.

Authors:  Akiko Hayashi; Hiroshi Ohnishi; Hideki Okazawa; Seshiru Nakazawa; Hiroshi Ikeda; Sei-ichiro Motegi; Naoko Aoki; Shoji Kimura; Masahiko Mikuni; Takashi Matozaki
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

Review 2.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

3.  Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites.

Authors:  Robert M Anthony; Joseph F Urban; Farhang Alem; Hossein A Hamed; Cristina T Rozo; Jean-Luc Boucher; Nico Van Rooijen; William C Gause
Journal:  Nat Med       Date:  2006-07-30       Impact factor: 53.440

Review 4.  Pathophysiology of graft-versus-host disease directed to minor histocompatibility antigens.

Authors:  R Korngold
Journal:  Bone Marrow Transplant       Date:  1991       Impact factor: 5.483

Review 5.  Exploiting graft-versus-tumour responses using donor leukocyte infusions.

Authors:  K S Peggs; S Mackinnon
Journal:  Best Pract Res Clin Haematol       Date:  2001-12       Impact factor: 3.020

6.  Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses.

Authors:  Dimitrios Tzachanis; Alla Berezovskaya; Lee M Nadler; Vassiliki A Boussiotis
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

7.  Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response.

Authors:  Pratima Sinha; Virginia K Clements; Stephanie K Bunt; Steven M Albelda; Suzanne Ostrand-Rosenberg
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

8.  CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

Authors:  Machteld M Tiemessen; Ann L Jagger; Hayley G Evans; Martijn J C van Herwijnen; Susan John; Leonie S Taams
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

Review 9.  Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation.

Authors:  Andrew R Rezvani; Rainer F Storb
Journal:  J Autoimmun       Date:  2008-01-31       Impact factor: 7.094

10.  The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells.

Authors:  Guangwei Liu; Kai Yang; Samir Burns; Sharad Shrestha; Hongbo Chi
Journal:  Nat Immunol       Date:  2010-09-19       Impact factor: 25.606

View more
  15 in total

1.  Mesh induced fibrosis: The protective role of T regulatory cells.

Authors:  Amanda M Artsen; Matthew Rytel; Rui Liang; Gabrielle E King; Leslie Meyn; Steven D Abramowitch; Pamela A Moalli
Journal:  Acta Biomater       Date:  2019-07-19       Impact factor: 8.947

2.  TSC1 controls IL-1β expression in macrophages via mTORC1-dependent C/EBPβ pathway.

Authors:  Tao Yang; Linnan Zhu; Yanhua Zhai; Qingjie Zhao; Jianxia Peng; Hongbing Zhang; Zhongzhou Yang; Lianfeng Zhang; Wenjun Ding; Yong Zhao
Journal:  Cell Mol Immunol       Date:  2015-05-25       Impact factor: 11.530

3.  Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects.

Authors:  Ivana Nikolic; Tamara Saksida; Katia Mangano; Milica Vujicic; Ivana Stojanovic; Ferdinando Nicoletti; Stanislava Stosic-Grujicic
Journal:  Diabetologia       Date:  2014-02-02       Impact factor: 10.122

4.  Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer.

Authors:  Catharina Hagerling; Hugo Gonzalez; Kiarash Salari; Chih-Yang Wang; Charlene Lin; Isabella Robles; Merel van Gogh; Annika Dejmek; Karin Jirström; Zena Werb
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

5.  TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide.

Authors:  Fan Yang; Yang Li; Tingting Wu; Ning Na; Yang Zhao; Weiguo Li; Chenlu Han; Lianfeng Zhang; Jun Lu; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2016-03-02       Impact factor: 4.599

6.  Early Immunomodulatory Effects of Implanted Human Perivascular Stromal Cells During Bone Formation.

Authors:  Carolyn A Meyers; Jiajia Xu; Lei Zhang; Greg Asatrian; Catherine Ding; Noah Yan; Kristen Broderick; Justin Sacks; Raghav Goyal; Xinli Zhang; Kang Ting; Bruno Péault; Chia Soo; Aaron W James
Journal:  Tissue Eng Part A       Date:  2017-08-15       Impact factor: 3.845

7.  PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.

Authors:  Karen M Henkels; Naveen Reddy Muppani; Julian Gomez-Cambronero
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

8.  Transcriptional and metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages.

Authors:  Rob J W Arts; Theo S Plantinga; Sander Tuit; Thomas Ulas; Bas Heinhuis; Marika Tesselaar; Yvette Sloot; Gosse J Adema; Leo A B Joosten; Johannes W A Smit; Mihai G Netea; Joachim L Schultze; Romana T Netea-Maier
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

Review 9.  Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging.

Authors:  Brandon Coder; Weikan Wang; Liefeng Wang; Zhongdao Wu; Qichuan Zhuge; Dong-Ming Su
Journal:  Oncotarget       Date:  2017-01-24

10.  Indirubin Increases CD4+CD25+Foxp3+ Regulatory T Cells to Prevent Immune Thrombocytopenia in Mice.

Authors:  Aijun Zhang; Bin Ning; Nianzheng Sun; Jianlu Wei; Xiuli Ju
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.